| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 28, 2010Data from 1,500-Patient IN.PACT(TM) Clinical Program Presented at TCT; First Patient Enrolled in European Study on Device's Use in SFA Disease
WASHINGTON, Sep 28, 2010 (BUSINESS WIRE) -- Advancing research on drug-eluting balloons for the treatment of coronary and peripheral artery disease, Medtronic, Inc. (NYSE: MDT), today announced...
-
Sep 23, 2010Announced at Clinton Global Initiative, an initial $1 million in grants are part of an overall strategic effort to reduce the burden of chronic disease
MINNEAPOLIS, Sep 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. today announced at the Clinton Global Initiative a $1 million commitment to the NCD Alliance. The grants are made in preparation for...
-
Sep 20, 2010Superior Deliverability Distinguishes New Medical Device Based on Engineering Advance of Continuous Sinusoid Technology
MINNEAPOLIS, Sep 20, 2010 (BUSINESS WIRE) -- Delivering another innovation for interventional cardiology, Medtronic, Inc. (NYSE: MDT), announced today the U.S. Food and Drug Administration (FDA)...
-
Sep 20, 2010Consistent Results in More Than 3,600 Patients from Complex Daily Practice of Interventional Cardiology Strengthen Evidence on Implantable Heart Device
WASHINGTON, Sep 22, 2010 (BUSINESS WIRE) -- Coronary artery disease, a leading cause of death and poor quality of life worldwide, runs the gamut from simple to complex, which complicates the daily...
-
Sep 17, 2010Initial Results Suggest ONS Warrants Further Study for Control of Chronic Migraine
MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced that data from a multicenter, prospective, randomized, blinded, feasibility trial published today show promise...
-
Sep 17, 2010Interventional Cardiology Meeting Features New Data on Resolute(R) Drug-Eluting Stent, IN.PACT(TM) Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve
MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Representing the broadest range of medical technology for the interventional treatment of cardiovascular disease,Medtronic, Inc. (NYSE: MDT), today...
-
Sep 16, 2010Further Clinical Study Required for Application to U.S. Food and Drug Administration
MINNEAPOLIS, Sep 16, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the company has received CE (Conformité Européenne) Mark approval for Medtronic Deep Brain...
-
Sep 14, 2010
MINNEAPOLIS, Sep 14, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the UBS Global Life Sciences...
-
Sep 13, 2010System Supports Proactive Patient Care for Patients at Risk for Worsening Heart Failure
MINNEAPOLIS, Sep 13, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today introduced the CareLink(R) Network for Heart Failure, an extension of the world's largest remote implantable cardiac...
-
Sep 13, 2010Medical Device Leader Recognized for Corporate Sustainability
MINNEAPOLIS, Sep 13, 2010 (BUSINESS WIRE) -- Recognizing its leadership in meeting the needs of economic, environmental, and social stakeholders, Medtronic, Inc. (NYSE: MDT) has been named a...
-
Sep 10, 2010"Innovating for a Better World" Reviews Company's Economic, Social and Environmental Performance for Fiscal Year 2010
MINNEAPOLIS, Sep 10, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) has released "Innovating for a Better World," the company's 2010 Corporate Citizenship Report. The online report, which...
-
Sep 7, 2010
Resolute Integrity Stent Launched in the UK Medtronic, Inc. (NYSE: MDT), announces the CE (Conformite Europeene) mark and international launch of the Resolute Integrity Stent System for the...
-
Sep 7, 2010Innovative Technology Advances Greater Ease of Use Advantage for Physicians During CoreValve Transcatheter Valve Implantation
MINNEAPOLIS, Sep 07, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité Européenne) Mark approval and the first global use and launch of the Medtronic...
-
Sep 3, 2010
MINNEAPOLIS, Sep 03, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Morgan Stanley Global...
-
Aug 26, 2010Medtronic Ablation Frontiers Cardiac Ablation System Delivers Treatment for the Most Common Heart Arrhythmia
MINNEAPOLIS & BRAMPTON, Ontario, Aug 26, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it received Health Canada approval for the Medtronic Ablation Frontiers Cardiac...
-
Aug 25, 2010
MINNEAPOLIS, Aug 25, 2010 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.225 per share of the company's common stock. The dividend is...
-
Aug 25, 2010
MINNEAPOLIS, Aug 25, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that it has pledged $100,000 through the Medtronic Foundation to support flooding relief efforts in...
-
Aug 24, 2010Updates Fiscal Year 2011 Revenue Outlook and EPS Guidance
MINNEAPOLIS, Aug 24, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2011, which ended July 30, 2010. The company reported...
-
Aug 17, 2010Acquisition Will Expand Product Offering, Pipeline and New Markets for Biologics Business
MEMPHIS, Tenn., Aug 17, 2010 (BUSINESS WIRE) -- Medtronic Inc., (NYSE: MDT) and Osteotech, Inc., (NASDAQ: OSTE) today announced that the companies have signed a definitive agreement under which...
-
Aug 16, 2010
MINNEAPOLIS, Aug 16, 2010 (BUSINESS WIRE) -- Medtronic investors and other interested parties are invited to participate in a live Webcast of the Medtronic Annual Shareholder Meeting on Wednesday,...
-
Aug 13, 2010
MINNEAPOLIS, Aug 13, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the first quarter of its fiscal year 2011 on Tuesday, August 24, 2010....
-
Aug 12, 2010
MINNEAPOLIS, Aug 12, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has completed its acquisition of ATS Medical, Inc. following payment of $4.00 per share in cash for each...
-
Aug 6, 2010Milestone Shows Progress on Indication-Specific Trials for Treating Peripheral Arterial Disease
MINNEAPOLIS, Aug 06, 2010 (BUSINESS WIRE) -- With an expanded focus on addressing peripheral arterial disease (PAD), Medtronic, Inc. (NYSE: MDT), today announced that it has completed enrollment...
-
Aug 5, 2010Minimally Invasive Procedure May Stabilize Bleeding and Improve Clinical Outcomes
MINNEAPOLIS, Aug 05, 2010 (BUSINESS WIRE) -- Marking a major milestone toward expanding the use and utility of minimally invasive endovascular procedures, Medtronic, Inc. (NYSE: MDT), today...
-
Jul 29, 2010Medtronic Launches Novel Clinical Trial Evaluating Spinal Cord Stimulation Therapy for Heart FailureDefeat-HF Trial Aims to Slow HF Progression with Neurostimulation
MINNEAPOLIS, Jul 29, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the global launch of the Defeat-HF (Determining the Feasibility of Spinal Cord Neuromodulation for the...